GSK2374697

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2015

2015

GSK2374697, a long duration glucagon‐like peptide‐1 (GLP‐1) receptor agonist, reduces postprandial circulating endogenous total GLP‐1 and peptide YY in healthy subjects

J. Lin, R. Hodge, R. O'Connor‐Semmes, D. Nunez
Diabetes, obesity & metabolism
2015

Corpus ID: 21165108

We investigated the effects of a long‐duration glucagon‐like peptide‐1 (GLP‐1) receptor agonist, GSK2374697, on postprandial… Expand

2014

2014

GSK2374697, a Novel Albumin‐Binding Domain Antibody (AlbudAb), Extends Systemic Exposure of Exendin‐4: First Study in Humans—PK/PD and Safety

R. O'Connor‐Semmes, J. Lin, +4 authors D. Nunez
Clinical pharmacology and therapeutics
2014

Corpus ID: 19835083

GSK2374697 is a genetically engineered fusion protein of a human domain antibody to exendin‐4. This molecule binds with a high… Expand